Neuroscientific Biopharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is AU$0.005; its P/E ratio is 11.30; Neuroscientific Biopharmaceuticals Ltd. is scheduled to report earnings on August 30, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19
Income Statement	-
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
EBIT	-	-	-	-
EBITDA	-	-	-	-
Net Income Common Stockholders	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 7.22M	AU$ 14.16M	AU$ 3.29M	AU$ 4.61M
Total Assets	AU$ 7.74M	AU$ 14.83M	AU$ 3.74M	AU$ 5.12M
Total Debt	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -7.22M	AU$ -14.16M	AU$ -3.29M	AU$ -4.61M
Total Liabilities	AU$ 2.22M	AU$ 223.41K	AU$ 88.53K	AU$ 62.48K
Stockholders Equity	AU$ 5.52M	AU$ 14.60M	AU$ 3.65M	AU$ 5.06M
Cash Flow	-
Free Cash Flow	-	-	-	-
Operating Cash Flow	-	-	-	-
Investing Cash Flow	-	-	-	-
Financing Cash Flow	-	-	-	-

Currency in AUD

Neuroscientific Biopharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Neuroscientific Biopharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Neuroscientific Biopharmaceuticals Ltd. Cash Flow

Cash Flow >

Neuroscientific Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing